Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 8, 2014, after the close
10-Q filed Aug 8, 2014, 39 days after period end · 0001144204-14-047843
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $5.00K | $2.50K | $78.13K | $0.00 |
| Net Income | -$6.75M | -$6.25M | -$2.38M | -$3.65M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.09 |
| -$0.04 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
